City
Epaper

Over 3.1 bn Covid-19 vaccine doses administered in Chinese mainland

By IANS | Updated: February 24, 2022 16:05 IST

Beijing, Feb 24 Over 3.1 billion Covid-19 vaccine doses had been administered on the Chinese mainland, so far, ...

Open in App

Beijing, Feb 24 Over 3.1 billion Covid-19 vaccine doses had been administered on the Chinese mainland, so far, data from the National Health Commission showed Thursday.

The number increased by almost 6 million from Tuesday, according to the commission.

On Saturday, Wu Liangyou, an official with the commission, announced that China's health authorities were rolling out sequential Covid booster vaccinations following the approval of the State Council inter-agency task force for Covid response.

The Chinese mainland on Wednesday reported 85 locally transmitted Covid cases, including 40 in Inner Mongolia, according to the commission.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Wu liangyouchinabeijingState CouncilNational Health CommissionThe national health commissionHealth commissionChina commissionRussian federation councilChina national health commissionNational health commission of china
Open in App

Related Stories

InternationalIndian Vlogger Detained for 15 Hours at Chinese Airport Over Arunachal Pradesh Stance

EntertainmentChahat Khanna Rings in Christmas Early in China With Festive Celebrations

InternationalMexico Approves 50% Tariff Hike on Indian and Chinese Imports

InternationalHong Kong Fire Tragedy: Death Toll Rises to 44, Nearly 300 Still Missing

CricketAsia Cup Rising Stars 2025 Points Table: Updated Standings After Group Stage Ends With Bangladesh A vs Sri Lanka A Match

Health Realted Stories

HealthGujarat's Foster Parent Scheme provides lifeline to orphaned children in Banaskantha

HealthFSSAI cracks down on ‘herbal tea’, says only Camellia sinensis qualifies

HealthPunjab CM approves cashless treatment of Rs 10 lakh to every family

HealthGST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026

HealthSun Pharma’s Taro recalls over 17,000 units of antifungal shampoo in US: FDA